Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neuropharmacology
2019 Oct 01;157:107691. doi: 10.1016/j.neuropharm.2019.107691.
Show Gene links
Show Anatomy links
α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M
,
Valdes A
,
Christensen SB
,
Tran PT
,
Watkins M
,
Gajewiak J
,
Jensen AA
,
Olivera BM
,
McIntosh JM
.
???displayArticle.abstract???
α6-containing (α6*) nicotinic acetylcholine receptors (nAChRs) are expressed throughout the periphery and the central nervous system and constitute putative therapeutic targets in pain, addiction and movement disorders. The α6β2* nAChRs are relatively well studied, in part due to the availability of target specific α-conotoxins (α-Ctxs). In contrast, all native α-Ctxs identified that potently block α6β4 nAChRs exhibit higher potencies for the closely related α6β2β3 and/or α3β4 subtypes. In this study, we have identified a novel peptide from Conus ventricosus with pronounced selectivity for the α6β4 nAChR. The peptide-encoding gene was cloned from genomic DNA and the predicted mature peptide, α-Ctx VnIB, was synthesized. The functional properties of VnIB were characterized at rat and human nAChRs expressed in Xenopus oocytes by two-electrode voltage clamp electrophysiology. VnIB potently inhibited ACh-evoked currents at rα6β4 and rα6/α3β4 nAChRs, displayed ∼20-fold and ∼250-fold lower potencies at rα3β4 and rα6/α3β2β3 receptors, respectively, and exhibited negligible effects at eight other nAChR subtypes. Interestingly, even higher degrees of selectivity were observed for hα6/α3β4 over hα6/α3β2β3 and hα3β4 receptors. Finally, VnIB displayed fast binding kinetics at rα6/α3β4 (on-rate t½ = 0.87 min-1, off-rate t½ = 2.7 min-1). The overall preference of VnIB for β4* over β2* nAChRs is similar to the selectivity profiles of other 4/6 α-Ctxs. However, in contrast to previously identified native α-Ctxs targeting α6* nAChRs, VnIB displays pronounced selectivity for α6β4 nAChRs over both α3β4 and α6β2β3 receptors. VnIB thus represents a novel molecular probe for elucidating the physiological role and therapeutic properties of α6β4* nAChRs.
Abraham,
Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails.
2018,
Pubmed
Akondi,
Discovery, synthesis, and structure-activity relationships of conotoxins.
2014,
Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Azam,
Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors.
2005,
Pubmed
,
Xenbase
Azam,
α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.
2010,
Pubmed
,
Xenbase
Azam,
Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
2006,
Pubmed
Azam,
Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.
2002,
Pubmed
Azam,
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.
2009,
Pubmed
Bertrand,
Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors.
2015,
Pubmed
Bertrand,
The wonderland of neuronal nicotinic acetylcholine receptors.
2018,
Pubmed
Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase
Champtiaux,
Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice.
2002,
Pubmed
Chua,
GABAA Receptors and the Diversity in their Structure and Pharmacology.
2017,
Pubmed
Craig,
An O-glycosylated neuroexcitatory conus peptide.
1998,
Pubmed
Dowell,
Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase
Dutertre,
Beta2 subunit contribution to 4/7 alpha-conotoxin binding to the nicotinic acetylcholine receptor.
2005,
Pubmed
,
Xenbase
Dutton,
A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activity.
2002,
Pubmed
Franco,
RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
2012,
Pubmed
,
Xenbase
Giribaldi,
α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors.
2018,
Pubmed
Gotti,
Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferents.
2005,
Pubmed
Grishin,
Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Hernández-Vivanco,
Monkey adrenal chromaffin cells express α6β4* nicotinic acetylcholine receptors.
2014,
Pubmed
Hone,
Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Hone,
A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors.
2009,
Pubmed
,
Xenbase
Hone,
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtype.
2012,
Pubmed
Hone,
α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.
2015,
Pubmed
,
Xenbase
Hone,
α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
2012,
Pubmed
,
Xenbase
Hone,
α9-containing nicotinic acetylcholine receptors and the modulation of pain.
2018,
Pubmed
Johnson,
alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
1995,
Pubmed
,
Xenbase
Kaas,
ConoServer, a database for conopeptide sequences and structures.
2008,
Pubmed
Kaas,
ConoServer: updated content, knowledge, and discovery tools in the conopeptide database.
2012,
Pubmed
Kelley,
Two toxins from Conus striatus that individually induce tetanic paralysis.
2006,
Pubmed
Kompella,
Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
2015,
Pubmed
,
Xenbase
Kuryatov,
Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses.
2000,
Pubmed
,
Xenbase
Le Novère,
Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain.
1996,
Pubmed
Lebbe,
Conotoxins targeting nicotinic acetylcholine receptors: an overview.
2014,
Pubmed
Letchworth,
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.
2011,
Pubmed
Luo,
Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Luo,
alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.
1998,
Pubmed
,
Xenbase
Luo,
Characterization of a novel α-conotoxin from conus textile that selectively targets α6/α3β2β3 nicotinic acetylcholine receptors.
2013,
Pubmed
,
Xenbase
Lynch,
Glycine Receptor Drug Discovery.
2017,
Pubmed
McIntosh,
A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
2005,
Pubmed
,
Xenbase
McIntosh,
Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes.
1999,
Pubmed
McIntosh,
Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
2004,
Pubmed
,
Xenbase
Miwa,
Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.
2011,
Pubmed
Moretti,
Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience.
2004,
Pubmed
Nguyen,
Isolation, purification and functional characterization of alpha-BnIA from Conus bandanus venom.
2014,
Pubmed
Nicke,
Isolation, structure, and activity of GID, a novel alpha 4/7-conotoxin with an extended N-terminal sequence.
2003,
Pubmed
,
Xenbase
Olivera,
Subtype-selective conopeptides targeted to nicotinic receptors: Concerted discovery and biomedical applications.
2008,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Picciotto,
Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states.
2015,
Pubmed
Pérez-Alvarez,
Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland.
2012,
Pubmed
Quik,
α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.
2011,
Pubmed
Quik,
Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.
2011,
Pubmed
Robinson,
Conotoxin gene superfamilies.
2014,
Pubmed
Romeo,
Conus ventricosus venom peptides profiling by HPLC-MS: a new insight in the intraspecific variation.
2008,
Pubmed
Santos,
The A-superfamily of conotoxins: structural and functional divergence.
2004,
Pubmed
Smith,
Comparative functional expression of nAChR subtypes in rodent DRG neurons.
2013,
Pubmed
Talley,
Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
2006,
Pubmed
,
Xenbase
Taly,
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
2009,
Pubmed
Teichert,
Discovery and characterization of the short kappaA-conotoxins: a novel subfamily of excitatory conotoxins.
2007,
Pubmed
,
Xenbase
Terlau,
Conus venoms: a rich source of novel ion channel-targeted peptides.
2004,
Pubmed
Walstab,
5-HT(3) receptors: role in disease and target of drugs.
2010,
Pubmed
Wieskopf,
The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.
2015,
Pubmed
Yu,
Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.
2018,
Pubmed
Yuan,
From the identification of gene organization of alpha conotoxins to the cloning of novel toxins.
2007,
Pubmed
